There is a continuing need to provide high-quality, timely, and clinically relevant cardiovascular education. This 2nd Edition of “Microbubbles in Practice” has been updated with new content to reflect the latest developments in the field. In this program, we provide an overview of ultrasound enhancing agents (UEAs) and the types of UEAs currently available in the United States. We review the historical and updated safety data on UEAs, discuss contemporary approaches to managing adverse reactions, and evaluate current indications for UEA use along with the evolving evidence base supporting their efficacy in clinical practice. These updates will equip physicians and sonographers with the most current information and data to make well-informed decisions in their clinical settings.
- Review the efficacy and cost-effectiveness of UEAs in the ED and ICU
- Understand the best practices for use of UEAs in echocardiography laboratories and the role of decision aides
- Review billing/coding for UEA use in echocardiography
This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), and other healthcare professionals involved in echocardiography.
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Valid from TBD | Expires: TBD
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with ineligible companies. Additionally, in the event a relevant financial relationship does exist, it is the policy of NWIF to ensure that the relevant financial relationship is mitigated in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
Jordan Strom, MD, MSc, FACC, FASE
- Philips Healthcare – Consultant
- Edwards Lifesciences – Grant Funding
Jordan B. Strom, MD, MSc, FACC, FASE
Associate Professor of Medicine,
Harvard Medical School,
Director, Echocardiography Laboratory,
Beth Israel Deaconess Medical Center,
Boston, MA
